Brandywine Oak Private Wealth’s Charles River Laboratories CRL Stock Holding History

Brandywine Oak Private Wealth’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,375	Closed	-$294K	–	299
2022 Q2	$294K	Buy	1,375 +523	+61%	+$128K	0.04%	247
2022 Q1	$241K	Buy	852 +178	+26%	+$54.9K	0.03%	311
2021 Q4	$264K	Sell	674 -89	-12%	-$34.6K	0.03%	286
2021 Q3	$314K	Sell	763 -31	-4%	-$12.9K	0.04%	242
2021 Q2	$293K	Sell	794 -129	-14%	-$43.1K	0.03%	253
2021 Q1	$267K	Sell	923 -44	-5%	-$12.2K	0.04%	231
2020 Q4	$241K	Sell	967 -92	-9%	-$21.9K	0.04%	238
2020 Q3	$239K	Sell	1,059 -143	-12%	-$29.7K	0.04%	224
2020 Q2	$209K	Buy	+1,202	New	+$192K	0.04%	236
2019 Q1	–	Sell	-1,095	Closed	-$125K	–	294
2018 Q4	$125K	Buy	+1,095	New	+$137K	0.03%	253

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Brandywine Oak Private Wealth's CRL Position: Q3 2022 in Review

Brandywine Oak Private Wealth sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,375 shares — an estimated $294K sold.

Brandywine Oak Private Wealth first reported a position in CRL in Q4 2018 and held it in 10 quarters. The position peaked at $314K in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

Brandywine Oak Private Wealth reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
Brandywine Oak Private Wealth sold 1,375 Charles River Laboratories shares in Q3 2022, an estimated $294K.
Brandywine Oak Private Wealth first reported a position in Charles River Laboratories in Q4 2018 and held it in 10 quarters.
Brandywine Oak Private Wealth's Charles River Laboratories position peaked at $314K in Q3 2021.
583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Brandywine Oak Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.